Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS BLMK Clinical Commissioning Group
Capability House
Silsoe, Bedfordshire
MK45 4HR
UK
Person cyswllt: Samuel Naxton
E-bost: samuel.naxton@attain.co.uk
NUTS: UKH24
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.blmkccg.nhs.uk/
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Community Lipid Management Service
Cyfeirnod: ACE-0490-2021-BLMK
II.1.2) Prif god CPV
85100000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
NHS BLMK Clinical Commissioning Group has awarded a contract to Evexia Health Ltd following an 'Open' procurement process to deliver a new Community Lipid Management Service.
The purpose of the Community Lipid Service is to provide a consistent, evidence-based approach to lipid management across BLMK CCG. The Community Lipid Clinic will form part of a new pathway developed with key stakeholders across BLMK, in line with evidenced-based best practice. The service will be funded to provide clinical activity to optimise lipid management in populations at very high risk of CVD (as defined by the commissioner) and provide clinical assessment for familial hypercholesterolemia in people meeting appropriate clinical criteria (as defined by the commissioner), in line with locally developed evidence-based pathways. The Community Lipid Clinic will accept referrals of people meeting the relevant clinical criteria who are registered with a GP practice in Bedfordshire, Luton and Milton Keynes Integrated Care System.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 200 000.00 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKH24
Prif safle neu fan cyflawni:
Bedfordshire, Luton and Milton Keynes
II.2.4) Disgrifiad o’r caffaeliad
NHS BLMK CCG secured Pathway Transformation Funding (PTF) to support the adoption of a new lipid management pathway and the establishment of community lipid services. The Community Lipid service will offer:
• A full assessment of people referred with CVD and/or FH and also uncontrolled hypercholesterolaemia or mixed dyslipidemia, including review of current and previous lipid lowering treatments, adherence with treatment regimes and any reasons for discontinuation.
• Pharmacological management and monitoring of effectiveness and tolerability in line with pathways agreed with the commissioner.
• Requesting of appropriate pathology tests at appropriate intervals through the relevant pathology system.
• Electronic prescription of relevant medications, in sufficient quantity to meet the requirements for uptitration between review contacts.
• Comprehensive documentation of each clinical contact in the shared clinical record on SystmOne.
• Support for self-management and education on the significance of managing cardiovascular risk factors, including cholesterol.
• Appropriate signposting to other services to support optimisation of health and wellbeing, including weight management, smoking cessation, alcohol support and talking therapies.
• Onward referral to specialist lipid services of patients with uncontrolled lipids despite maximum tolerated oral therapy, in line with criteria and pathways agreed with the commissioner.
• Clinical assessment of people with clinical features suggestive of suspected FH (as defined by the commissioner), with onward referral as appropriate to specialist lipid services.
• Clear treatment plans with appropriate patient-driven uptitration of therapy, timing of repeat lipid testing and scheduling of follow-up to allow maximal impact from each clinical contact.
II.2.5) Meini prawf dyfarnu
Maes prawf ansawdd: Quality
/ Pwysoliad: 100%
Price
/ Pwysoliad:
0%
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Ydy
Disgrifiad o’r opsiynau:
Contract duration is for 12 months (01st January 2022 to 31st December 2022) with an option to extend for a further 12 months subject to funding, learning and benefits outcomes.
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn agored
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2021/S 000-018335
Section V: Dyfarnu contract
Rhif Contract: M1J4AY Community Lipid Service 2021-22
Teitl: Community Lipid Service
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
27/10/2021
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 2
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Evexia Health Ltd
2a Malzeard Road
Luton
LU3 1BD
UK
NUTS: UKH21
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 200 000.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
Contract Duration:
12 months with an option to extend for a further 12 months subject to funding, learning and benefits outcomes.
Contract Value:
£100,000 per annum
Total contract value for a 24 month period:
£200,000
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
High Court of Justice of England and Wales
Strand
London
WC2A 2LL
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
24/11/2021